Abstract-Angiotensin II induces the development of vascular hypertrophy and hypertension. An increasing number of studies have demonstrated that reactive oxygen species are involved in many of the vascular responses to angiotensin II. However, the role of specific cell types and the precise identity of the functionally relevant reactive oxygen species remain unclear. In this study, we established a line of transgenic mice with vascular smooth muscle cell (SMC)-specific overexpression of the human catalase gene to explicitly test the functional role of vascular smooth muscle-derived hydrogen peroxide in the hypertensive and hypertrophic responses to angiotensin II in vivo. Catalase overexpression was confirmed by increased expression of catalase mRNA and protein, as well as by an increase in catalase enzymatic activity. The catalase transgenic mice were viable, had no change in basal hydrogen peroxide release (0.36Ϯ0.03 versus 0.37Ϯ0.14 mol/L), and showed no overt developmental abnormality. In response to angiotensin II treatment, catalase transgenic mice exhibited lower hydrogen peroxide release compared with control animals. There was no effect on the hypertensive response to angiotensin II (147Ϯ10 versus 148Ϯ12 mm Hg (Ang II) plays an important role in the development of vascular hypertrophy 1,2 and hypertension. [3] [4] [5] The immediate hypertensive effects of Ang II occur as a result of vasoconstriction and antinatriuresis. 6 Chronically, Ang II causes remodeling of the arterial vasculature via cellular hypertrophy. In the spontaneously hypertensive rat and the 1-kidney, 1-clip model of hypertension, administration of either an angiotensinconverting enzyme inhibitor or an Ang II receptor antagonist results in significantly reduced vascular hypertrophy. 7 Similarly, Ang II infusion, but not norepinephrine infusion, causes vascular hypertrophy. 8 Together, these data clearly indicate the potential importance of Ang II in vascular hypertrophy.
A mong other pathological factors, angiotensin II (Ang II) plays an important role in the development of vascular hypertrophy 1,2 and hypertension. [3] [4] [5] The immediate hypertensive effects of Ang II occur as a result of vasoconstriction and antinatriuresis. 6 Chronically, Ang II causes remodeling of the arterial vasculature via cellular hypertrophy. In the spontaneously hypertensive rat and the 1-kidney, 1-clip model of hypertension, administration of either an angiotensinconverting enzyme inhibitor or an Ang II receptor antagonist results in significantly reduced vascular hypertrophy. 7 Similarly, Ang II infusion, but not norepinephrine infusion, causes vascular hypertrophy. 8 Together, these data clearly indicate the potential importance of Ang II in vascular hypertrophy.
Numerous studies have suggested that reactive oxygen species (ROS) such as superoxide anion and H 2 O 2 are involved in the hypertensive and hypertrophic responses to Ang II. 9 -12 In vascular smooth muscle cells (SMCs), the NAD(P)H oxidase is one of the major sources of superoxide and H 2 O 2 . 13, 14 Ang II increases intracellular superoxide, which can be readily converted into H 2 O 2 by superoxide dismutase (SOD). Ang II-mediated increases in intracellular H 2 O 2 are inhibited by extracellular catalase, the NAD(P)H oxidase inhibitor diphenylene iodonium, and the Ang II type 1 receptor antagonist losartan, suggesting that in vascular SMCs (VSMCs), Ang II increases intracellular H 2 O 2 via a mechanism involving activating the NAD(P)H oxidase via the Ang II type 1 receptor. 10, 13 ROS have been implicated in hypertension in human studies of essential hypertension and experimental animal models of hypertension. 13, [15] [16] [17] [18] Superoxide anion has been clearly implicated in pathogenesis of hypertension, per se. [11] [12] [13] 17 However, the role of H 2 O 2 remains obscure because previous studies have suggested a role for H 2 O 2 in vasoconstriction and vasorelaxation. 19 -23 Elevated plasma concentrations of H 2 O 2 were observed in salt-sensitive Dahl rats. 15 Several in vitro studies have shown that H 2 O 2 was able to elicit contractions in artery segments from various species and locations such as human umbilical artery, 24, 25 rabbit carotid artery, 26 and rat aorta, 27 as well as pulmonary artery. 28 Conversely, there are reports that H 2 O 2 induces relaxation of endothelium-denuded aortic rings from spontaneously hypertensive rats. 29, 30 In the same species, catalase, but not SOD, attenuated the K ϩ -channel opener levcromakalim-induced relaxation. 31 Thus, whereas the role of superoxide anion in hypertension is relatively clear, the role of H 2 O 2 remains less well defined.
As suggested by several in vitro studies, ROS may also be involved in Ang II-mediated vascular hypertrophy. 9, 10 Whereas superoxide anion has not been directly implicated in Ang II-induced vascular hypertrophy, several lines of evidence suggest that H 2 O 2 may be the principal ROS involved in this pathological process. Ang II increases intracellular H 2 O 2 in VSMCs, and overexpression of catalase results in an inhibition of the subsequent VSMC hypertrophy in vitro. 10, 32 Despite the fact that Ang II has acute (vasoconstriction) and chronic (vascular hypertrophy) effects on the arterial vasculature and that there are ample data to support a role for ROS in both of these effects, the specific role of H 2 O 2 in Ang II-mediated vasoconstriction and vascular hypertrophy remains unclear. To directly assess the role of H 2 O 2 in Ang II-mediated hypertension and hypertrophy in vivo, we generated a line of transgenic mice with VSMC-specific overexpression of catalase. Using this unique model, we show that in the setting of Ang II-induced hypertension, vascular hypertrophy, but not hypertension itself, is mediated by VSMC H 2 O 2.
Materials and Methods

Generation and Genotyping of the Transgenic Mice Overexpressing Human Catalase
To develop smooth muscle-specific overexpression of catalase, we used a Cre/LoxP system (for details, please see the supplement, available online at http://www.hypertensionaha.org).
All mice used in this study, including the transgenic mice and the wild-type control mice (littermates of the transgenic mice), were on a C57/BL6 background. All procedures were approved by the Emory University institutional animal care and use committee and were in compliance with the standards for the care and use of laboratory animals of the Institute of Laboratory Animal Resources, National Academy of Sciences, Bethesda, Md.
Measurement of the Expression of Catalase mRNA From the Transgene
Two micrograms of total mRNA isolated from each of the wild-type and Tg cat-SMC aortas was reverse transcribed and polymerase chain reaction (PCR) amplified with primers that flanked a region of catalase cDNAs. In this region, there is an SphI site that is species specific to the human catalase gene and an EcoRV site that is species specific for the native mouse catalase gene. Thus, SphI and EcoRV digestion of the PCR products can be used to specifically identify the human catalase gene expression in murine tissues.
Measurement of Catalase Enzymatic Activity in Aortic Tissue
The total catalase enzymatic activity in aorta was measured for each of the control and transgenic mice (4 mice for each type) using a colorimetric assay. After perfusing the mouse aorta with cold 0.9% saline, the aorta was harvested and placed in cold isotonic buffer containing 0.01% digitonin. The adventitial tissues were quickly removed from aorta. The aorta was then homogenized in 200 L cold isotonic buffer containing 0.01% digitonin. After spinning the homogenate at 700g for 10 minutes, the supernatant (Ϸ100 L) was collected for the assay of enzymatic activity. The turnover rate of 10 mol/L H 2 O 2 catalyzed by the supernatant was measured at 240 . The catalase activity of the samples was represented by the K value calculated with the formula Kϭ(2.3/⌬t)(logA1/A2), in which A1 and A2 were the absorbance of the samples at 0 and 60 seconds. 33 The K value was normalized to the protein concentration of each sample.
Immunostaining of Catalase in the Aorta Tissue Sections
Tissue sections from paraffin-embedded aortas were subjected to fluorescent immunostaining using an antibody raised against human catalase (Athens Research and Technology). The tissue sections were blocked with 1% gelatin/PBS and treated with the primary antibody (1:100 dilution) at room temperature for 1 hour. After washing with 1ϫPBS, slides were treated with the secondary antibody (fluorescein isothiocyanate-labeled goat-anti rabbit antibody; Jackson Immunoresearch Laboratories, Inc.) at room temperature for 30 minutes. Sections were washed with 1ϫPBS and then counterstained for nuclei with Hoechst solution.
Ang II Treatment
Eight transgenic mice and 10 control mice (12 weeks old) were anesthetized, and an osmotic mini-pump (Alzet model 2001 or 2002) filled with Ang II was implanted subcutaneously in the midscapular region. Ang II was infused at a rate of 0.75 mg/kg per day. This dose has been shown previously by us and others to induce a modest degree of systolic hypertension. 34, 35 Ten transgenic mice and 10 control mice were subjected to a sham operation for use as controls. Blood pressures were measured with a noninvasive computerized tail-cuff system (BP2000 Visitech) as described previously. 34 After opening the aorta with scissors and washing out the blood, the aorta was placed in buffer alone at 37°C. Ninety minutes later, duplicate 50-L aliquots were taken from each of the tubes and the concentration of H 2 O 2 measured according to the protocol provided by the manufacturer. Superoxide anion was quantitatively assessed using an high-performance liquid chromatography-based method for quantification of dihydroethidium. 36 
Measurement of ROS
Measurement of Arterial Wall Hypertrophy
For the analysis of vascular hypertrophy, all animals were perfused with saline and subsequently pressure fixed at 100 mm Hg with buffered formalin. Five-micrometer serial sections of paraffinembedded aortas were stained with hematoxylin and eosin for histological evaluation. Digital photomicrographs of aortic sections were analyzed using NIH Image, with the wall thickness defined as the distance between the outer and inner elastic lamine. The thickness of each aortic wall was represented by the average of 8 measurements made 45°C apart around the circumference of the aortic ring.
Statistical Analysis
All results are presented as the meanϮSEM. Statistical significance was determined by ANOVA to evaluate the difference between individual treatment groups.
Results
Detection of Mouse and Human Catalase Gene Expression
To discriminate between native mouse catalase gene expression and transgenic human catalase gene expression, we took advantage of differences in unique restriction sites in a 403-bp PCR product generated from mouse and human catalase cDNA. After reverse transcribing total mRNAs isolated from mouse aortas and PCR amplifying this region of catalase cDNAs, the digestion of the PCR products with restriction enzyme SphI or EcoRV was indicative of the relative amounts cDNA derived from the transgene and from the endogenous mouse catalase gene ( Figure 1A ). Using this strategy, we were able to demonstrate in Tg cat-SMC animals a significant amount of PCR product that was cut by SphI, which is indicative of robust expression of the human catalase gene ( Figure 1B ).
Phenotypic Characterization of Transgenic Mice
To confirm that the catalase overexpression indeed resulted in an increase in enzymatic activity, we assayed for catalase enzymatic activity in aortic tissue harvested from Tg cat-SMC mice and their wild-type littermates. The results showed that aortic catalase enzymatic activity of the Tg cat-SMC mice was Ϸ2-fold higher than that of their wild-type littermates ( Figure  2A ). Immunostaining indicated that the overexpression of the human catalase gene was indeed confined to VSMCs ( Figure  2B ). Other antioxidant enzyme systems were not altered in the Tg cat-SMC mice ( Figure 2B ). There was no obvious effect of smooth muscle-specific overexpression of the catalase gene on litter size, body weight, vascular development, or other physical descriptors. (Figure 3) . Conversely, there was no significant effect of catalase overexpression on superoxide production ( Figure 4 ). Expression of the human catalase transgene was evaluated by taking advantage of the fact that there are unique restriction digestion sites in a specific region of the human and mouse catalase cDNAs. We detected the production of human catalase mRNA in aortas of Tg cat-SMC mice by reverse transcription of total catalase mRNA in mouse aorta, PCR amplification of that region, and SphI and EcoRV digestion of the resultant PCR product (Figure 2A) . Figure 2B shows an agarose gel demonstrating that part of the PCR products is digested by SphI into 2 DNA fragments (335 and 68 bp) but not by EcoRV, indicating that a significant amount of additional catalase mRNA production is generated by the transgenes. 
Catalase Overexpression Does Not Alter the Hypertensive Response to Ang II Infusion
To determine the effects of a reduction in H 2 O 2 production on blood pressure, we measured the blood pressures of wild-type and Tg cat-SMC mice under basal conditions and after treatment with Ang II (0.75 mg/kg per day) for 2 weeks ( Figure 5 ). We found that there was no significant difference in baseline blood pressure between the Tg cat-SMC mice and their wild-type littermates (102Ϯ10 versus 106Ϯ6 mm Hg; PϭNS). Similarly, there was no difference in the hypertensive response to Ang II between the Tg cat-SMC mice and their wild-type littermates (147Ϯ10 versus 148Ϯ12 mm Hg; PϭNS).
Catalase Overexpression Significantly Inhibits Ang II-Induced Vascular Hypertrophy
To test the hypothesis that the reduction in H 2 O 2 production by VSMCs leads to diminished Ang II-induced vascular hypertrophy, we measured aortic wall thickness of the Tg cat-SMC mice and their corresponding littermates with or without Ang II treatment. Comparisons were made using tissue sections from approximately the same location of aortas. The results showed that without Ang II treatment, there was no difference in the aortic wall thickness between the Tg cat-SMC mice and the wild-type mice. In wild-type mice, Ang II treatment resulted in a 84.1% increase (from 23.4Ϯ1.2 to 43.2Ϯ7.6 m) in wall thickness, whereas in Tg cat-SMC mice, Ang II caused only a 32.3% increase (from 24.5Ϯ2.1 to 32.4Ϯ2.0 m) in wall thickness (PϽ0.05; Figure 6 ). These findings demonstrate the importance of H 2 O 2 in Ang II-induced vascular hypertrophy independent of any effect on blood pressure.
Discussion
The data presented here demonstrate that in the setting of Ang II-induced hypertension, H 2 O 2 plays a central and critical role in the development of vascular hypertrophy. Conversely, we have also shown that H 2 O 2 appears not to be an important mediator of Ang II-induced hypertension. Numerous studies have previously shown that Ang II is a potent mediator of several pathological processes involving the arterial wall including vascular hypertrophy. 1, 2, 7, 8 A common mediator of Ang II effects on many tissues is the generation of ROS (including superoxide anion and H 2 O 2 ) via activation of the NADPH oxidase. 13, 37 Although there is considerable evidence from in vitro studies supporting a role for H 2 O 2 in Ang II-induced vascular cell hypertrophy, to date, there have been no studies that have examined the functional importance of H 2 O 2 in Ang II-induced hypertension and the subsequent hypertrophic response of the arterial wall in vivo. In this study, we approached this question by genetically manipulating the level of intracellular H 2 O 2 in VSMCs by overexpressing the catalase gene specifically in SMCs. By doing so, we are able to examine the impact of the changes in H 2 O 2 levels on Ang II-induced hypertrophy and hypertension. Thus, we have shown that although smooth VSMC H 2 O 2 appears not to be involved in the hypertensive response to Ang II infusion, H 2 O 2 is a critical mediator of Ang II-induced vascular hypertrophy in vivo.
For the purposes of this study, we generated a unique transgenic mouse (Tg cat-SMC ) that selectively overexpresses the human catalase gene in SMCs. Although there was no overt gross phenotypic difference in these mice compared with their wild-type littermates, we did document a significant increase in SMC-specific catalase protein expression and enzymatic activity within the arterial wall. Basal H 2 O 2 production by the arterial wall was not different between Tg cat-SMC mice and their wild-type littermates suggesting that: (1) there was a compensatory change in the amount of H 2 O 2 generated, (2) other cell types are the primary cellular source of basal H 2 O 2 production, or (3) basal catalase enzymatic activity was not rate limiting. However, in the setting of Ang II infusion, H 2 O 2 production was significantly reduced in the Tg cat-SMC mice. Thus, it appears that although overexpression of catalase in SMCs resulted in increased protein expression and enzymatic activity, effects of the overexpression were only Figure 4 . Ang II-induced superoxide production in aortic segments from Tg cat-SMC and wild-type (WT) mice. Animals were treated with Ang II as described in Methods, and superoxide was measured using dihydroethidium. *PϽ0.001 vs corresponding vehicle-treated animals. Figure 5 . Baseline blood pressure and hypertensive response to Ang II in Tg cat-SMC mice and their wild-type (WT) littermates. Nine Tg cat-SMC mice and 9 wild-type littermates (12 weeks old) were treated with Ang II (0.75 mg/kg per day) for 2 weeks, whereas an equal number of Tg cat-SMC and wild-type mice of the same age were subjected to a sham pump implantation. There was no significant difference in the baseline blood pressure or in the hypertensive response between the Tg cat-SMC mice and the wildtype littermates. *PϽ0.001 vs vehicle-treated animals. 9 -12,15 However, it is not clear which ROS are the causative agents in hypertension. A number of studies using animals with genetic forms of hypertension (spontaneously hypertensive rats, salt-dependent Dahl hypertensive rats) demonstrated a strong association between the production of ROS and blood pressure. 15, 16 Hypertensive patients have been reported to have significantly higher levels of plasma peroxides when compared with normotensive subjects. 38 In addition, it appears that plasma H 2 O 2 production correlates directly with plasma renin activity, suggesting a role for H 2 O 2 in Ang II-related regulation of blood pressure. 38 Systemic treatment with SOD attenuates Ang II-induced hypertension, suggesting that superoxide may be the predominant ROS that cause hypertension. 11, 12 This may occur via direct effects on the VSMCs, via degradation of NO, or both. 17,39,40 H 2 O 2 has been suggested to induce vasoconstriction 24 -28 and vasorelaxation. 29 -31 A recent study by Yang et al concluded that the overexpression of catalase in a nontissue-specific fashion did significantly reduce the hypertensive effect of Ang II. It is important to note that these authors showed an effect of catalase overexpression on norepinephrine-induced hypertension as well. 41 This finding is somewhat surprising given that other studies have shown that norepinephrine-induced hypertension is not mediated by ROS. We observed no differences in blood pressure between the Tg cat-SMC and wild-type mice under either baseline conditions or during Ang II infusion using the noninvasive tail-cuff technique to measure blood pressure. This technique is useful for measuring significant changes in systolic blood pressure but may not be as useful as the more invasive telemetry techniques. 42 Thus, we may have not been able to detect more subtle changes in blood pressure. However, the similarity in the systolic blood pressures in the Ang II-treated Tg cat-SMC mice and the Ang II-treated wild-type mice suggest that H 2 O 2 in VSMCs does not significantly contribute to the regulation of blood pressure in this model of hypertension. Together with other published studies, it appears that either superoxide or H 2 O 2 in a different cell type is likely to be more important in terms of arterial hypertension.
H 2 O 2 has also been implicated as a critical second messenger for Ang II-induced vascular hypertrophy. 32, 43 We found no difference in the aortic wall thickness between Tg cat-SMC and wild-type mice under baseline conditions. However, in the setting of Ang II-induced hypertension, vascular wall hypertrophy was significantly and dramatically reduced in the Tg cat-SMC mice. The reduction of vascular hypertrophy was concurrent with the inhibition of Ang II-induced H 2 O 2 production in the Tg cat-SMC mice. Importantly, this inhibition of vascular wall hypertrophy occurred in the face of no obvious change in arterial blood pressure. These findings indicate that at least part of the hypertrophic effect of Ang II occurs independently of the hypertensive effect of Ang II infusion. This finding is consistent with the results from studies performed using cultured VSMCs, showing that Ang IImediated protein synthesis and cellular hypertrophy in vitro are mediated by H 2 O 2 resulting from activation of the NAD(P)H oxidase. 32, 43 There are several aspects of this model that warrant discussion. First, because H 2 O 2 is generally considered to be freely diffusible across the cell membrane, overexpression of catalase in smooth muscle does not necessarily mean that the source of H 2 O 2 is the smooth muscle. However, the results obtained in our experimental model demonstrate that intracellular H 2 O 2 in the VSMCs is a critical mediator of vascular hypertrophy. In addition, it is also important to realize that we did not study resistance vessels in this model. Our findings in aortic tissues may not be directly applicable to resistance vessels. Finally, it has been proposed recently that catalase may have peroxidase-like activity that could potentially yield a biological response independent of reductions in hydrogen peroxide. 44 Although the potential conflicting effects of a peroxidase-like function is a possibility, peroxidase-like activity has only been demonstrated in the setting of the addition of significant concentrations of exogenous catalase to a nonvascular cell culture system. In summary, we used a novel transgenic mouse model with SMC-specific overexpression of the human catalase gene to examine the physiological importance of H 2 
